Lv11
40 积分 2025-03-24 加入
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
6小时前
待确认
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis
6小时前
已完结
Assessment of Dosing Strategies for Pediatric Drug Products
1个月前
已关闭
Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs
1个月前
已完结
皖公网安备34019202002308
